Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention

Table 2 Clinical outcomes at 24-month follow-up

Adverse Events	Group 1 (174)	Group 2 (64)	Group 3 (112)	P value
Adverse Events	Group 1 (174)	Group 2 (64)	Group 3 (112)	overall	1 vs 2	1 vs 3	2 vs 3
All-cause death	2 (1.1%)	5 (7.8%)	21 (18.8%)	< 0.001	0.007	< 0.001	0.048
MACCEs	6 (3.4%)	7 (10.9%)	28 (25%)	< 0.001	0.024	< 0.001	0.025
Cardiac death	1 (0.6%)	2 (3.1%)	21 (18.8%)	< 0.001	0.116	< 0.001	0.004
Stent thrombosis	2 (1.1%)	0 (0)	1 (0.9%)	0.7	0.390	0.874	0.418
Repeat revascularization	2 (1.1%)	4 (6.3%)	4 (3.6%)	0.085	0.024	0.111	0.532
MI	2 (1.1%)	0 (0)	3 (2.7%)	0.264	0.403	0.268	0.170
Stroke	0 (0)	1 (1.6%)	1 (0.9%)	0.296	0.161	0.161	0.776

Values expressed are n (%). MACCEs major adverse cardiac and cerebrovascular event, includes cardiac death, stent thrombosis, repeat revascularization, MI and stroke, MI myocardial infarction

ISSN: 1471-2261